SCI program (AcurePharma/AnaMar Medical)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSCI program (AcurePharma/AnaMar Medical)
Drug Alias NameAM-250 SCIguanabenz (AcurePharma)anti-inflammatory/MC receptor modulator (AnaMar)AM-250 program (AcurePharma)AMAP-713 +[6] 
ClassificationSmall molecules
Mechanisms of ActionMelanocortin receptor agonistsNeuroprotectants
TargetsMelanocortin receptor
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcure Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMar-MedAcure Pharma AB
Active IndicationsN/A
Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A